Recent research of stem cells in mice has produced a more precise way to deliver chemotherapy to the tumor microenvironment of metastatic cancer. As opposed to targeting cancer cells directly, as other stem cell research has aimed to achieve, this delivery method targets the cells in their home, which could have a greater effect on the cancer cells. This method could prove to be more dynamic, allowing patients with different needs to have more tailored treatment. http://bit.ly/2yjfO9t
- Can expanded access give insight into the future success or failure of a new treatment?
- How could research of stem cells improve the delivery of cancer drugs to metastatic tumors?
- Could wider inclusion of minority patients in clinical trials actually lower the cost of healthcare overall?
- New Waiver in IRB Process Speeds FDA Single Patient Expanded Access Approval; Updated Information available on WCGF website.
- How could a new treatment, given previously under expanded access, successfully treat a serious disease of the eye?